Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Q3 Trading Update

31 Oct 2019 07:00

RNS Number : 6889R
Elementis PLC
31 October 2019
 

Elementis plc

Q3 Trading Update

Delivering further performance in 2019, broadly in line with expectations

Solid overall trading in Personal Care, Coatings & Talc

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 30 September 2019.

Whilst the slowdown in broader macroeconomic conditions continues, self-help actions are anticipated to result in an improved second half performance, broadly in line with expectations. The Group's strong free cash generation continued in Q3.

The Talc integration is now complete with functional teams embedded and delivery of synergies on track. The Group remains focused on executing its plans to transform Coatings, grow Personal Care and expand Talc. This strategy, supported by self-help measures focused on cost efficiency and cash delivery will provide a robust financial platform to deliver future growth and shareholder value creation.

Business performance

·; Personal Care had a steady third quarter with solid performance in cosmetics and further sequential volume improvement in anti-perspirant actives, with margins impacted by tariffs. We continue to make progress on new product launches targeting the skin care market.

 

·; In Coatings, demand conditions were in line with expectations. Whilst activity modestly improved in the North American and Asian architectural markets, industrial coatings demand remained sluggish across all geographies. Margins were resilient supported by cost savings, new product launches and price/mix improvements.

 

·; In Talc performance was in line with expectations with strong demand for high value industrial applications such as technical ceramics and coatings, offsetting weak plastics. A much improved second half performance continues to be expected driven by new business, cost synergies and nickel sales phasing.

 

·; Whilst Energy is a small part of Elementis, performance was weaker than expected due to a further slowdown in North American drilling activity. As a result, second half performance is anticipated to significantly decline on the first six months.

 

·; In Chromium, pricing in our rest of the world operations further weakened, reflecting lower global industry capacity utilisation and increased competitive intensity. Performance in North America, where our operations enjoy significant structural advantages, has remained relatively robust. As a result, performance in the second half is anticipated to be broadly in line with the first six months of 2019.

 

Commenting on the performance, CEO, Paul Waterman said,

"Whilst market conditions remain challenging, overall performance in Personal Care, Coatings and Talc has been in line with expectations due to our self-help actions. Although there are no signs of improvement in global economic conditions, the fundamentals of our business remain strong. We are confident about our significant medium term innovation, growth and efficiency opportunities. This will be the focus of our Capital Markets Day in November."

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTURRNRKKAROAA
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.